-
Most Recent
Search Results
240 results for COV
TTOO Stock Alert: T2 Biosystems Seeks Approval for Reverse Stock Split
TTOO stock investors are anticipating T2’s annual meeting next month. Up for vote is a reverse stock split.
AI’s Gold Rush: Tech Winners, Job Shake-Ups, and Powering the Boom
In this week’s Being Exponential, I break down why the AI boom still has plenty of upside — and why timing is everything. From Nvidia’s…
Sorrento Therapeutics Is Charming But Read the Label
Undoubtedly, Sorrento Therapeutics’ Henry Ji has done a fantastic job marketing SRNE stock. But as the Covid-19 race narrows, the probability of winning declines significantly.
5 Bogus Buybacks at Big-Name Stocks
Buyback programs can bolster faith in a company, but those at AOL, TiVo, Southwest, Covidien, and HP raise serious questions.
Novavax News: NVAX Stock Surges 14% as Human Trial for Coronavirus Vaccine Nears
Novavax (NVAX) news for Wednesday concerning a trial for a vaccine to treat the coronavirus from China has NVAX stock flying high.
OraSure Technologies News: Why OSUR Stock Is Surging 13% Today
OraSure Technologies (OSUR) is in the news Monday after announcing approval from the FDA for one of its devices sent OSUR stock soaring.
Fluidigm News: Why FLDM Stock Is Soaring 30% Today
Fluidigm (FLDM) news for Wednesday concerning EUA from the FDA to test for the novel coronavirus has FLDM stock rocketing higher.
What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors
Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing.
TNXP Stock: The Huge Covid-19 News Boosting Tonix Pharmaceuticals Today
TNXP stock is up today with news that the company is joining with a biotech company to commercialize a new coronavirus therapy.
The Market’s Uptrend Is Under Fire
The Russell 2000 and the Nasdaq have begun to show some holes and are now perched on critical technical support.
Regeneron Pharmaceuticals Stock Shoots Up 8% on Trump Treatment
Regeneron Pharmaceuticals (REGN) stock is soaring Monday on news that its treatment for the coronavirus was used on President Trump.
Use Johnson & Johnson for Quick Income
Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.
Opendoor’s Rebirth: Can the Army Turn Meme Momentum Into Millions?
Opendoor is back from the brink with new leadership, fresh capital, and a bold AI-driven strategy. Is it the biggest turnaround of 2025?
What Is Going on With Edesa Biotech (EDSA) Stock Today?
Edesa Biotech released encouraging Phase 2 results for its respiratory-syndrome-targeting antibody, thus initially boosting EDSA stock.
The Bright Future Behind Genomic Sequencing
Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here’s what investors need to know now.
Jobs, Inflation, Bonds, Earnings – What to Expect
As you know, I am expecting a key interest rate cut during this meeting. I discussed why in this week’s Navellier Market Buzz. We also…
3 Balanced Mutual Funds for a Smooth Ride
These three balanced mutual funds aren’t just for conservative investors — they’re for anyone nervous about the stock market.
Is It Time to Dump These 4 Health Care ETFs?
These four funds’ holdings stand to lose big on health care reform, regardless of the Supreme Court ruling. Investors should assess the damage from the…
VRPX Stock: What Investors Are Saying About Virpax Pharma as Shares Continue to Fly
Shares of VRPX stock continue to blow up on Wednesday after Virpax Pharmaceuticals’ massive business announcement on Tuesday.
8 – 10 of 240 results
